Europe Approves Bristol Myers' Cell Therapy Breyanzi For Patients With Certain Type Of Blood Cancer
EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...
Foreign Office alert to anyone travelling to 29 European countries of major change in travel rules - full list
The Foreign Office today informed anyone travelling to 29 European countries that the EU is planning a major change towards ...
GlobalData on MSN11h
EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy
The EC has granted expanded approval to BMS' Breyanzi, to treat adults with relapsed or refractory follicular lymphoma (FL).
TheBusinessDesk.com9h
Etex opens £170m plasterboard factory in Bristol
Etex Group has unveiled its largest-ever investment with the opening of a new plasterboard manufacturing facility in Bristol.
Bristol Myers Gets Expanded European Approval for Breyanzi
Bristol Myers Squibb has won European Commission expanded approval of its CAR-T cell therapy Breyanzi in the blood cancer lymphoma.
Medical Dialogues1d
Bristol Myers Squibb gets European Commission nod for Breyanzi for follicular lymphoma
Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has granted approval to Breyanzi ...
Investing.com India3d
European Commission expands approval for Bristol Myers Squibb’s lymphoma therapy
Investing.com -- The European Commission has granted Bristol Myers (NYSE: BMY) Squibb, the biopharmaceutical company based in ...
Huge £168m plasterboard factory opens near Bristol Port
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Etex opens 200 million euros plasterboard manufacturing facility in Bristol, UK
Etex, a global lightweight construction materials manufacturer, has officially opened its 200 million euros expansion of its plasterboard production ...